1. Composition containing glutathione reductase GSSG-r and oxidized glutathione GSSG or its pharmaceutically acceptable salts, for use as a medicine. The composition for use according to claim 1, wherein said use is to reduce cell damage caused by the loss of redox balance of the cell, to protect against the toxic effects of radicals formed during radiolysis of cell water, as well as in the treatment and prevention of viral and bacterial infections. . The composition for use according to claim 1, containing GSSG and GSSG-r in a ratio of mass / volume, in the range from 1: 4 to 1: 1 or from 1: 2.5 to 1: 1.5, where the content of the specified GSSG- r is at least 100 enzyme units / ml. 4. The composition for use according to claim 3, containing GSSG and a suspension of GSSG-r in a mass / volume ratio of 1: 2.5. The composition for use according to claim 3, containing approximately 0.500 mg of GSSG and at least 100 units of GSSG-r in 1 ml. The composition for use according to claim 3, wherein the functional dose contains at least 400 units of GSSG-r and about 2 mg of GSSG, and it is about 4 ml of said composition. The composition for use according to claim 1, where the ratio of mass / PE / ml, where PE / ml is the enzymatic units of glutathione reductase per ml of solution, is in the range from 1: 100 to 1: 3600, or from 1: 400 to 1: 2000 , or from 1: 600 to 1: 1000.8. The composition for use according to claim 1 in the form of a pharmaceutical preparation. The composition for use according to claim 2, wherein said viral disease is caused by a DNA virus or an RNA virus with or without a virus envelope, or a retrovirus. The composition for use according to claim 7, wherein said viral disease is caused by an influenza virus, according to1. Композиция, содержащая глутатионредуктазу GSSG-r и окисленный глутатион GSSG или его фармацевтически приемлемые соли, для применения в качестве лекарственного средства.2. Композиция для применения по п.1, где указанное применение заклю
